Pancreatic Cancer Remains a Deadly Disease. Why?
- Published in:
- JOP Journal of the Pancreas, 2022, v. 23, n. 11, p. 114, doi. 10.35841/1590-8577-23.11.777
- By:
- Publication type:
- Article
Works matching IS 15908577 AND DT 2022 AND VI 23 AND IP 11
Results: 5
1
2
Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis.
- Published in:
- JOP Journal of the Pancreas, 2022, v. 23, n. 11, p. 104, doi. 10.35841/1590-8577-23.11.773
- By:
- Publication type:
- Article
3
Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs).
- Published in:
- JOP Journal of the Pancreas, 2022, v. 23, n. 11, p. 110, doi. 10.35841/1590-8577-23.11.775
- By:
- Publication type:
- Article
4
Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas.
- Published in:
- JOP Journal of the Pancreas, 2022, v. 23, n. 11, p. 112, doi. 10.35841/1590-8577-23.11.776
- By:
- Publication type:
- Article
5
Clinical Presentations of Rare Pancreatic Neuroendocrine Neoplasms (panNENs).
- Published in:
- JOP Journal of the Pancreas, 2022, v. 23, n. 11, p. 108, doi. 10.35841/1590-8577-23.11.774
- By:
- Publication type:
- Article